C
Caris Life Sciences Inc
NASDAQ:CAI
Caris Life Sciences Inc
NASDAQ:CAI
Price:
18.38
USD
-3.62%
Market Closed
Market Cap:
$5.2B
Income Statement
Earnings Waterfall
Caris Life Sciences Inc
Caris Life Sciences Inc
Income Statement
Caris Life Sciences Inc
Caris Life Sciences Inc
Currency:
| Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
32
|
45
|
0
|
|
| Revenue |
715
N/A
|
931
+30%
|
812
-13%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(363)
|
(433)
|
(271)
|
|
| Gross Profit |
351
N/A
|
499
+42%
|
541
+8%
|
|
| Operating Income | ||||
| Operating Expenses |
(684)
|
(799)
|
(496)
|
|
| Selling, General & Administrative |
(522)
|
(615)
|
(396)
|
|
| Research & Development |
(162)
|
(184)
|
(100)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
|
| Operating Income |
(333)
N/A
|
(300)
+10%
|
45
N/A
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(104)
|
(113)
|
(93)
|
|
| Non-Reccuring Items |
(18)
|
(18)
|
(20)
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(456)
N/A
|
(432)
+5%
|
(68)
+84%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
0
|
|
| Income from Continuing Operations |
(456)
|
(432)
|
(68)
|
|
| Net Income (Common) |
(1 022)
N/A
|
(998)
+2%
|
(538)
+46%
|
|
| EPS (Diluted) |
-3.63
N/A
|
-3.35
+8%
|
-3.22
+4%
|
|
Switch to:
Switch to:
See Also
Discover More
